SNO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
Radiation oncology at SNO 2026
Nov 12–15, 2026 Philadelphia, PA ~3k attendees Website
49 organizations at SNO 2026 present work in radiotherapy, radiobiology and radiopharmaceuticals: 25 universities and institutes and 24 hospitals and cancer centers. Between them they bring 569 presentations to the program. Most represented: Mayo Clinic, University of California, San Francisco (UCSF) and Cleveland Clinic. As of Nov 12, 2026.
Format
Top represented
Showing 1–1 of 49 organizations
| Organization | SNO 2026 Attendance |
|---|---|
Mayo Clinic Rochester, MN | |
A nonprofit academic medical center with cancer programs and neuro-oncology care and research across its campuses. | Session Thu Nov 12 8:30–8:40am Session Thu Nov 12 8:40–9:55am Session Thu Nov 12 10:10–11:45am Session Thu Nov 12 12:35–2:10pm Talk Thu Nov 12 12:35–2:10pm Talk Thu Nov 12 2–3:30pm Talk Thu Nov 12 2–3:30pm Session Thu Nov 12 2–3:30pm Session Thu Nov 12 4:25–4:30pm Talk Thu Nov 12 4:30–5:35pm Session Thu Nov 12 4:30–5:35pm Session Fri Nov 13 8:30–10am Plenary Fri Nov 13 8:30–10am Session Fri Nov 13 10:15–11:15am Session Fri Nov 13 10:15–11:15am Talk Fri Nov 13 10:22–10:29am Talk Fri Nov 13 10:54–10:59am Talk Fri Nov 13 10:59–11:04am Session Fri Nov 13 11:30am–12:30pm Talk Fri Nov 13 11:33–11:36am Session Fri Nov 13 12:45–2:15pm Session Fri Nov 13 2:30–3:30pm Talk Fri Nov 13 2:30–3:30pm Talk Fri Nov 13 2:30–3:30pm Talk Fri Nov 13 3:14–3:19pm Session Fri Nov 13 3:45–4:45pm Session Fri Nov 13 3:45–4:45pm Talk Fri Nov 13 3:45–4:45pm Session Fri Nov 13 5–6pm Talk Fri Nov 13 5–6pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Poster Fri Nov 13 7:30–9:30pm Session Sat Nov 14 8:30–10am Plenary Sat Nov 14 8:30–10am Session Sat Nov 14 10:15–11:15am Session Sat Nov 14 10:15–11:15am Talk Sat Nov 14 10:15–11:15am Talk Sat Nov 14 10:15–11:15am Talk Sat Nov 14 11:42–11:45am Talk Sat Nov 14 11:45–11:48am Talk Sat Nov 14 11:45–11:48am Talk Sat Nov 14 11:54–11:57am Talk Sat Nov 14 12:18–12:21pm Talk Sat Nov 14 12:21–12:24pm Session Sat Nov 14 12:45–2:15pm Session Sat Nov 14 2:30–3:30pm Talk Sat Nov 14 3:09–3:14pm Talk Sat Nov 14 4:24–4:29pm Session Sat Nov 14 5–6pm Session Sun Nov 15 8:30–9:30am Talk Sun Nov 15 8:30–9:30am Talk Sun Nov 15 9:45–10:45am Session Sun Nov 15 11am–12pm Talk Sun Nov 15 11am–12pm Talk Sun Nov 15 11:21–11:28am |
Find buyers in radiotherapy, radiobiology and radiopharmaceuticals
Tell us what you sell and we’ll find the people at organizations working on radiotherapy, radiobiology and radiopharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Browse SNO 2026 by
Organization type
Topic
- Tumor biology: signaling, metabolism, stem cells and the tumor microenvironment 106
- Cancer neuroscience: how neurons and brain tumors interact 54
- Immunobiology, immunotherapy and cell therapies 64
- Experimental therapeutics, drug discovery and resistance, drug delivery and tumor models 105
- Clinical trials, trial design and trials in progress 99
- Molecular pathology, tumor classification and (epi)genomics 102
- Biomarkers and liquid biopsy 53
- Neuroimaging, PET and response assessment 62
- Neurosurgery and surgical therapies 41
- Radiotherapy, radiobiology and radiopharmaceuticals 49
- Pediatric and adolescent and young adult (AYA) brain tumors 55
- Brain and leptomeningeal metastases 27
- Rare CNS tumors and tumor predisposition syndromes 34
- CNS lymphoma and neurohematology 13
- Survivorship, quality of life, cognition, neurologic complications and palliative care 105
- Health disparities, epidemiology and quality improvement 58
Everyone
Not affiliated with or endorsed by the Society for Neuro-Oncology. Submit a correction